Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority claimed from PCT/US1999/013947external-prioritypatent/WO2000002592A1/en
Publication of BR9911950ApublicationCriticalpatent/BR9911950A/en
Patente de Invenção: <B>"COMPOSIçãO FARMACêUTICA CONTENDO ANáLOGOS GABA E UM AGENTE ANTIVIRAL PARA TRATAMENTO DE HERPES ZOSTER"<D>. A presente invenção é um processo de uso de certos análogos de ácido glutâmico e ácido gama amino butírico em combinação com um agente antiviral para tratar herpes zoster.Invention Patent: <B> "PHARMACEUTICAL COMPOSITION CONTAINING GABA ANALOGS AND AN ANTIVIRAL AGENT TO TREAT HERPES ZOSTER" <D>. The present invention is a process of using certain analogs of glutamic acid and gamma amino butyric acid in combination with an antiviral agent to treat herpes zoster.
BR9911950-1A1999-06-181999-06-18
Pharmaceutical composition containing gaba analogs and an antiviral agent for the treatment of herpes zoster
BR9911950A
(en)
Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
Compound, process for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, and use of a compound and process to prepare it.